Genesis Molecular AI unifies AI and biotech, pairing proven drug developers with an advanced small-molecule discovery platform.
By bringing together drug developers, AI researchers, and software engineers, Genesis uses machine learning across the discovery pipeline to design and advance transformative new therapies faster than traditional methods allow.
Founders

Evan Feinberg
Co-Founder & CEO

Ben Sklaroff
Co-Founder & CTO